| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1160/TH07-01-0035 |
| P698 | PubMed publication ID | 17479179 |
| P50 | author | Christian Weber | Q37838769 |
| P2093 | author name string | Andreas Ludwig | |
| P433 | issue | 5 | |
| P921 | main subject | inflammation | Q101991 |
| transmembrane protein | Q424204 | ||
| P304 | page(s) | 694-703 | |
| P577 | publication date | 2007-05-01 | |
| P1433 | published in | Thrombosis and Haemostasis | Q15724413 |
| P1476 | title | Transmembrane chemokines: versatile 'special agents' in vascular inflammation. | |
| P478 | volume | 97 |
| Q34931211 | Adipose inflammation, insulin resistance, and cardiovascular disease |
| Q24300694 | An oxidized lipid-peroxisome proliferator-activated receptor gamma-chemokine pathway in the regulation of macrophage-vascular smooth muscle cell adhesion |
| Q37339764 | Atherogenic lipids induce high-density lipoprotein uptake and cholesterol efflux in human macrophages by up-regulating transmembrane chemokine CXCL16 without engaging CXCL16-dependent cell adhesion |
| Q96131764 | CX3CL1 homo-oligomerization drives cell-to-cell adherence |
| Q34698709 | CX3CL1, a chemokine finely tuned to adhesion: critical roles of the stalk glycosylation and the membrane domain |
| Q39698815 | CX3CR1/CX3CL1 axis negatively controls glioma cell invasion and is modulated by transforming growth factor-β1. |
| Q37197326 | CXCL16 is expressed in podocytes and acts as a scavenger receptor for oxidized low-density lipoprotein |
| Q43170301 | CXCR6 identifies a putative population of retained human lung T cells characterised by co-expression of activation markers. |
| Q35912993 | Cell surface localization and release of the candidate tumor suppressor Ecrg4 from polymorphonuclear cells and monocytes activate macrophages |
| Q37950973 | Chemokines: established and novel targets in atherosclerosis |
| Q47720267 | Cigarette Smoke Increases Endothelial CXCL16-Leukocyte CXCR6 Adhesion In Vitro and In Vivo. Potential Consequences in Chronic Obstructive Pulmonary Disease. |
| Q33602959 | Citrullination and proteolytic processing of chemokines by Porphyromonas gingivalis. |
| Q34009507 | Cloning and expression of ADAM-related metalloproteases in equine laminitis |
| Q36694094 | Equine Arteritis Virus Uses Equine CXCL16 as an Entry Receptor |
| Q34921351 | Fractalkine depresses cardiomyocyte contractility |
| Q34391705 | Fractalkine is expressed in early and advanced atherosclerotic lesions and supports monocyte recruitment via CX3CR1. |
| Q35591414 | Fractalkine over expression suppresses α-synuclein-mediated neurodegeneration |
| Q34407627 | Fractalkine/CX3CL1: a potential new target for inflammatory diseases |
| Q39669210 | Genome-wide association study among four horse breeds identifies a common haplotype associated with in vitro CD3+ T cell susceptibility/resistance to equine arteritis virus infection |
| Q33800749 | High Glucose Level Disturbs the Resveratrol-Evoked Curtailment of CX3CL1/CX3CR1 Signaling in Human Placental Circulation |
| Q35063189 | Mechanisms of urokinase plasminogen activator (uPA)-mediated atherosclerosis: role of the uPA receptor and S100A8/A9 proteins |
| Q40007020 | MicroRNA-223 controls the expression of histone deacetylase 2: a novel axis in COPD. |
| Q36893695 | Microglia and ischemic stroke: a double-edged sword |
| Q35158385 | Modulation of cellular signaling by herpesvirus-encoded G protein-coupled receptors |
| Q33869955 | Mouse aorta smooth muscle cells differentiate into lymphoid tissue organizer-like cells on combined tumor necrosis factor receptor-1/lymphotoxin beta-receptor NF-kappaB signaling |
| Q35802535 | Placental fractalkine is up-regulated in severe early-onset preeclampsia |
| Q37327764 | Plasmacytoid dendritic cell response to CpG ODN correlates with CXCL16 expression and is inhibited by ox-LDL |
| Q93090734 | Proteolytic chemokine cleavage as a regulator of lymphocytic infiltration in solid tumors |
| Q47140595 | RANTES/CCL5 Induces Collagen Degradation by Activating MMP-1 and MMP-13 Expression in Human Rheumatoid Arthritis Synovial Fibroblasts. |
| Q28072580 | Regulation of Chemokine Activity - A Focus on the Role of Dipeptidyl Peptidase IV/CD26 |
| Q33910700 | Relationships between markers of vascular dysfunction and neurodevelopmental outcomes in perinatally HIV-infected youth. |
| Q39691199 | Requirements for leukocyte transmigration via the transmembrane chemokine CX3CL1. |
| Q28393808 | Role of platelets in neuroinflammation: a wide-angle perspective |
| Q42201674 | Shear Stress Counteracts Endothelial CX3CL1 Induction and Monocytic Cell Adhesion. |
| Q64892909 | Systemic Inflammation in Metabolic Syndrome: Increased Platelet and Leukocyte Activation, and Key Role of CX3CL1/CX3CR1 and CCL2/CCR2 Axes in Arterial Platelet-Proinflammatory Monocyte Adhesion. |
| Q61811076 | The Multitasking Potential of Alarmins and Atypical Chemokines |
| Q39971704 | The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation |
| Q42074207 | The combined action of mast cell chymase, tryptase and carboxypeptidase A3 protects against melanoma colonization of the lung |
| Q28086874 | The ischemic environment drives microglia and macrophage function |
| Q24315412 | The role of CXCL16 and its processing metalloproteinases ADAM10 and ADAM17 in the proliferation and migration of human mesangial cells |
| Q36409902 | The soluble isoform of CX3CL1 is necessary for neuroprotection in a mouse model of Parkinson's disease. |
Search more.